Bellevue Life Sciences Acquisition Corp. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21
	10-K	10-K
Current assets:
Cash	0.1	0.0
Total current assets	0.1	0.0
Deferred offering costs	1.1	0.7
Total Assets	1.2	0.7

Current liabilities:
Accounts payable and accrued expenses	0.0	0.0
Accrued offering costs	0.0	0.3
Total current liabilities	1.3	0.7
Total liabilities	1.3	0.7

Commitments and Contingencies
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at June 30, 2023 and December 31, 2022
Common stock	0.0	0.0
Additional paid-in capital	0.0	0.0
Accumulated deficit	-0.1	0.0
Total stockholders’ deficit	0.0	0.0
Total Liabilities and Stockholders’ Deficit	1.2	0.7